Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft modelsChi-Heng Wu, Weiyun Z. Ai, Ryan M. Gill et al.|Blood Advances|2021Cited by 33
PHASE I STUDY OF ROMIDEPSIN AND LIPOSOMAL DOXORUBICIN IN RELAPSED OR REFRACTORY T‐CELL LYMPHOMAWeiyun Z. Ai, Jonathan E. Brammer, Khoan Vu et al.|Hematological Oncology|2019Cited by 0
T-cell clonality in peripheral blood as a predictor of progression to systemic treatment in patients with stage IB mycosis fungoides (MF).Suravi Raychaudhuri, Weiyun Z. Ai, Charli-Joseph Yann et al.|Journal of Clinical Oncology|2021Cited by 0
Abstract 5720: Targeting CDK9 in cutaneous T-cell lymphoma using patient-derived xenograft modelsYan-Jin Liu, Weiyun Z. Ai, Chi-Heng Wu et al.|Cancer Research|2024Cited by 0
Abstract 4226: Genome-wide CRISPRi screening identifies histone modification as a synergistic partner with JAK/STAT inhibition for enhancing anti-tumor activity in CTCL, validated in PDX-derived tumor cellsYan-Jin Liu, Weiyun Z. Ai, Laura Pincus et al.|Cancer Research|2025Cited by 0